insulin glargine


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

insulin glar·gine

 (glär′jēn′)
n.
A long-acting insulin analog whose amino acid sequence differs from that of human insulin by the substitution of glycine for asparagine at one end of the A chain and the addition of two arginines to the B chain, used in the treatment of type 1 and type 2 diabetes.

[gl(ycine) + arg(inin)ine.]
Mentioned in ?
References in periodicals archive ?
The recombinant human Insulin (rh-Insulin) and Insulin Glargine manufactured at this facility are addressing the needs of over 350,000 diabetic patients in Malaysia.
KEYWORDS: Elderly diabetics, Insulin Glargine, Acarbose.
Lannett announced the commencement of a human clinical trial of biosimilar insulin glargine, a product the company is co-developing with its strategic alliance partners within the HEC Group of companies, or HEC.
Biopharmaceutical company Sanofi revealed on Wednesday the receipt of approval from the US Food and Drug Administration (FDA) for the expanded use of Soliqua 100/33 (insulin glargine and lixisenatide injection) 100 units/ml and 33 mcg/ml.
It was observed with satisfaction that insulin glargine U300 that works like the human body's natural insulin and helps control blood sugar along with diet and exercise has been introduced after series of assessment in peculiar context of diabetes prevalent in the country.
KARACHI -- Sanofi announced the introduction of its next generation basal insulin (insulin glargine U300) in Pakistan at a scientific event attended by leading doctors.
Insulin glargine U300 is a novel long-acting basal insulin formulation that provides more stable effect than glargine U100.
Long-acting insulins (insulin detemir [Levemir[R]], insulin glargine [Lantus[R]]), and intermediate-acting insulin (NPH insulin) are used to provide basal insulin (Freeland, 2016).
(8,9) An even lower total daily dose of basal insulin as a marker for dose intensification has been suggested by a post hoc analysis of 3 insulin glargine titration studies of at least 24 weeks' duration (N=458).
The Max SoloStar pen holds more than 900 units of insulin glargine and can provide up to 160 units/mL in a single injection, which may reduce the number of injections needed to deliver the necessary dosage to adults.
AMERICANS SPENT more money on insulin glargine in 2015 than any other drug, and more than half of the 20 biggest-selling drugs for the year are regularly prescribed to patients with diabetes, according to the Agency for Healthcare Research and Quality.